Química en Ciencias Farmacéuticas
Departamento
Instituto de Investigaciones Biomédicas Alberto Sols
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Investigaciones Biomédicas Alberto Sols (8)
2022
-
Resveratrol-Based MTDLs to Stimulate Defensive and Regenerative Pathways and Block Early Events in Neurodegenerative Cascades
Journal of Medicinal Chemistry, Vol. 65, Núm. 6, pp. 4727-4751
2020
-
Tuning melatonin receptor subtype selectivity in oxadiazolone-based analogues: Discovery of QR2 ligands and NRF2 activators with neurogenic properties
European Journal of Medicinal Chemistry, Vol. 190
2019
-
The angiotensin-(1-7)/Mas receptor axis protects from endothelial cell senescence via klotho and Nrf2 activation
Aging Cell, Vol. 18, Núm. 3
2018
-
The APPswe/PS1A246E mutations in an astrocytic cell line leads to increased vulnerability to oxygen and glucose deprivation, Ca 2+ dysregulation, and mitochondrial abnormalities
Journal of Neurochemistry, Vol. 145, Núm. 2, pp. 170-182
-
Influence of Preparation Methods of Chitooligosaccharides on Their Physicochemical Properties and Their Anti-Inflammatory Effects in Mice and in RAW264.7 Macrophages
Marine drugs, Vol. 16, Núm. 11
-
Transcription factor NRF2 as a therapeutic target for chronic diseases: A systems medicine approach
Pharmacological Reviews, Vol. 70, Núm. 2, pp. 348-383
2009
-
Cytotoxicity mechanisms of pyrazino[1,2-b]isoquinoline-4-ones and SAR studies
Bioorganic and Medicinal Chemistry, Vol. 17, Núm. 23, pp. 8040-8047
2008
-
Pyrazino[1,2-b]isoquinolines: Synthesis and study of their cytostatic and cytotoxic properties
Bioorganic and Medicinal Chemistry, Vol. 16, Núm. 19, pp. 9065-9078